Merus N.V. revenue for the last year amounted to 43.95 M USD, the most of which — 43.95 M USD — came from its highest performing source at the moment, Innovative Therapeutics, the year earlier bringing 41.59 M USD. The greatest contribution to the revenue figure was made by Netherlands — last year it brought Merus N.V. 43.95 M USD, and the year before that — 41.59 M USD.